SensaSure Technologies IncOTCQB:SSTC
- LAST PRICE0.7500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.1650/ 100
- Ask / Lots100.0000/ 1
- Open / Previous Close0.0000 / 0.7500
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Apr 24, 2024
SensaSure Technologies and Verde Bio Holdings Provide Update on Pending Merger, from 8:00AM ET on Wednesday Apr 24, 2024 by Dow Jones
8:00AM ET on Wednesday Apr 24, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
SensaSure Technologies Inc | 42.3M | -21.8x | --- |
Immuneering Corp | 43.6M | -0.8x | --- |
Janone Inc | 43.8M | -1.4x | --- |
Carmell Corp | 40.2M | -1.4x | --- |
Apollomics Inc | 40.3M | -9.4x | --- |
IN8BIO, Inc. | 45.0M | -1.0x | --- |
Company Information
SensaSure Technologies, Inc. is a medical technology company. The Company is engaged in supplying a device and method to collect a breath sample for lab-based analysis. The Company's method is known as ExaBreath (EB) and it can collect, extract, detect and identify non-volatile compounds present in every exhaled breath by utilizing existing lab-based testing infrastructure and procedures. EB is applicable in toxicology, pharmacology, and clinical biochemistry. EB enhances the user experience in a range of applications and markets, such as workplace drug testing, anti-doping in sports, law enforcement, e-health, and telemedicine. The Company's testing methodology is a non-invasive way to collect chemicals in breath, for disease detection, exposure monitoring, and drug metabolism. EB detects a range of exogenous substances, such as drugs of abuse (narcotics), therapeutic drugs (antibiotics), and performance-enhancing drugs used in sports (stimulants), as well as many other compounds.
Contact Information
- Headquarters
- 505 Park Avenue, 4Th FloorNEW YORK, NY, United States 10022
- Phone
- 347-325-4677
- Fax
- ---
Executives
- Chairman of the Board, President
- Clarence Chan
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $42.3M |
|---|---|
Revenue (TTM) | $1.2K |
Shares Outstanding | 56.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.03 |
Book Value | $-0.02 |
P/E Ratio | -21.8x |
Price/Sales (TTM) | 36,749.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -123,834.80% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
